Q4 2024 · 13F-HR
Lepercq De Neuflize Asset Management LLCholdings as filed
Filed 2025-02-13 · accession 0001420506-25-000359
$139.5M
Reported value
14
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $67.5M | 48.4% | 115,245 | Common | SOLE |
| 464287465 | EFA | ISHARES TR | $35.2M | 25.3% | 466,000 | Common | SOLE |
| 46090E103 | QQQ | INVESCO QQQ TR | $23.7M | 17.0% | 46,278 | Common | SOLE |
| 464288257 | ACWI | ISHARES TR | $12.3M | 8.79% | 104,300 | Common | SOLE |
| 514766104 | LFCR | LIFECORE BIOMEDICAL INC | $168,661 | 0.12% | 22,700 | Common | SOLE |
| 961881208 | WETH | WETOUCH TECHNOLOGY INC | $120,279 | 0.09% | 67,954 | Common | SOLE |
| 74102L303 | SQFTEUR | PRESIDIO PPTY TR INC | $107,300 | 0.08% | 134,125 | Common | SOLE |
| 18270P109 | CLAR | CLARUS CORP NEW | $94,710 | 0.07% | 21,000 | Common | SOLE |
| 58471G508 | MDGSUSD | XYLO TECHNOLOGIES LTD | $94,334 | 0.07% | 26,059 | Common | SOLE |
| 294100102 | ENZB | ENZO BIOCHEM INC | $87,859 | 0.06% | 123,000 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $54,058 | 0.04% | 30,200 | Common | SOLE |
| 250639101 | DSWL | DESWELL INDS INC | $23,800 | 0.02% | 10,000 | Common | SOLE |
| 068221100 | BRN | BARNWELL INDS INC | $22,650 | 0.02% | 15,000 | Common | SOLE |
| 50186A132 | — | LGL GROUP INC | $3,956 | 0.00% | 26,200 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.